Spinogenix Receives Approval from the Australia Human Research Ethics Committee to Initiate a Phase 1 Human Clinical Trial of SPG302, a Novel Regenerative Drug for the Treatment of Amyotrophic Lateral Sclerosis (ALS) SAN DIEGO, July 10, 2023 (GLOBE NEWSWIRE) -- Spinogenix, Inc., a clinical-stage biopharmaceutical company developing novel small molecule drugs for neurological conditions, today announced that it...

Registration is Live for World’s Largest Advanced Therapies and Stem Cell Event with 2,000 Attendees Expected at Hyatt Regency Miami in January 2019 Miami, FL, Oct. 19, 2018 (GLOBE NEWSWIRE) -- The wait is over! Global leaders in advanced therapies, regenerative medicine and the stem cell field can register now for the co-located Phacilitate...

Life Science Leaders Announce Partnership for Pioneering Advanced Therapies Gathering in Miami 2019 Miami, FL, July 24, 2018 (GLOBE NEWSWIRE) -- Based on the success of the co-located World Stem Cell Summit and Phacilitate Leaders World conferences in January 2018, the Regenerative Medicine...

Leading Japanese Life Science Organizations to Exhibit at Biotech Convention in San Francisco CHICAGO, IL--(Marketwired - May 19, 2016) - Twenty-two Japanese life science companies and research institutions will exhibit in the Japan Pavilion (Booth 5514) at the 2016 BIO International...